DENMARK: Novozymes swoops for Iogen Bio-Products
By Richard Woodard | 31 January 2013
Leading bio-innovation business Novozymes has acquired Iogen Corporation subsidiary Iogen Bio-Products for a sum which could rise to C$80m (US$79.9m).
Join now for increased access
There are various access options to choose from. All provide instant access to the latest news, insight and expert analysis.
If you're already a member, login here.